HealthDay News — Individuals with hypertension are unlikely to measure their blood pressure (BP) at home as often as ...

HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...

HealthDay News — A fast-growing measles outbreak in South Carolina has eclipsed last year’s record-setting Texas surge. As of ...

No increased risk for death, acute neurosurgical operations, or length of hospitalization seen in association with ...

The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

AAP maintains routine vaccine recs despite CDC changes; FDA warns of serious injury with wound and burn products; subcutaneous Alzheimer disease treatment under review; Cardamyst nasal spray available ...

Topline results show eDSP failed to significantly improve RmICARS scores in ataxia-telangiectasia patients compared with placebo in the NEAT trial.

The researchers found that patients taking GLP-1 RAs had a significantly reduced incidence of revision FESS versus the non-GLP-1 RA group at one-year (risk ratio [RR], 0.64) and five-year follow-up ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

HealthDay News — More than 31,000 nurses and health care workers walked off the job Monday morning at Kaiser Permanente ...

Ivonescimab is a first-in-class, investigational bispecific antibody targeting programmed cell death protein 1 and vascular endothelial growth factor.

Many pediatricians are following vaccine guidance from the American Academy of Pediatrics, not the US Centers for Disease Control and Prevention ...